Shoar, S. and Shoar, N. and Naderan, M. and Modukuru, V.R. (2020) Regarding the publication �Rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation and stage IV-V chronic kidney disease�. American Heart Journal, 223. p. 110.
Full text not available from this repository.
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....
DOI: UNSPECIFIED
Item Type: | Article |
---|---|
Additional Information: | cited By 0 |
Uncontrolled Keywords: | rivaroxaban; warfarin, anticoagulant therapy; atrial fibrillation; bleeding; chronic kidney failure; follow up; gastrointestinal hemorrhage; hospitalization; human; kidney function; Letter; practice guideline; priority journal; renal replacement therapy |
Subjects: | Medicine Pharmacology, Toxicology and Pharmaceutics |
Divisions: | Faculty of Medicine > Clinical Sciences > Department of Cardiology |
Depositing User: | ART . editor |
Date Deposited: | 27 Jun 2020 12:29 |
Last Modified: | 27 Jun 2020 12:29 |
URI: | http://eprints.kaums.ac.ir/id/eprint/4923 |
Actions (login required)
![]() |
View Item |